My Fund

Loading your portfolio…

Checking your account and saved picks.

Choose a startup

Explore all 1324 companies in this selection. Research each company before making your pick.

Includes historical VC holdings. A listing does not confirm current ownership or startup stage.

VC tracking →

Showing 1–8 of 8 startups

Revolut

Collecting history

Product details not available yet.

Andreessen Horowitz
revolut.com ↗
Research Revolut

Tracking coverage

First reading saved. Waiting for a later comparable reading.

Momentum +1 · Collecting history
First reading saved. Waiting for a later comparable reading.Last reading:
Fundraising +2 · Awaiting data
No verified dated source evidence recorded.
New VC +3 · Awaiting data
No verified dated source evidence recorded.
Completed exit +10 · Awaiting data
Exit news coverage has not started.

Coverage describes public evidence. Points require a qualifying milestone after your pick.

What it does

Product details not available yet.

Visit revolut.com ↗

Tracked VC backing

A portfolio listing documents backing; its observation date is not an investment date.

Dated public activity

No dated funding or investment events recorded yet.

History is research context. Only qualifying milestones after your pick earn points.

Company and sources ↗

GC Therapeutics

Limited coverage

Bio + Health

Company website description

Discover GC Therapeutics, a pioneer in scalable, cutting-edge cell therapies designed to revolutionize treatment across a broad range of therapeutic areas.

Andreessen Horowitz
gc-tx.com ↗
Research GC Therapeutics

Tracking coverage

Some source history is available; coverage remains limited.

Momentum +1 · Limited coverage
The latest public index does not report a rank for this company.Index checked:
Fundraising +2 · Awaiting data
No verified dated source evidence recorded.
New VC +3 · Awaiting data
No verified dated source evidence recorded.
Completed exit +10 · Awaiting data
Exit news coverage has not started.

Coverage describes public evidence. Points require a qualifying milestone after your pick.

Company website description

Discover GC Therapeutics, a pioneer in scalable, cutting-edge cell therapies designed to revolutionize treatment across a broad range of therapeutic areas.

Visit gc-tx.com ↗Product description source ↗

Product source checked 31 Oct 2026

Source category

Bio + Health

Category source ↗

Checked

Tracked VC backing

A portfolio listing documents backing; its observation date is not an investment date.

Dated public activity

No dated funding or investment events recorded yet.

History is research context. Only qualifying milestones after your pick earn points.

Company and sources ↗

Peca Labs, Inc.

Limited coverage

Other Health Care

On its website, the company describes its work as “Founded by a group of Carnegie Mellon alumni including a pediatric surgeon, PECA Labs is revolutionizing cardiovascular implantable devices with a polymer platform and a…”.

No tracked VC backing recorded
pecalabs.com ↗
Research Peca Labs, Inc.

Tracking coverage

Some source history is available; coverage remains limited.

Momentum +1 · Limited coverage
The latest public index does not report a rank for this company.Index checked:
Fundraising +2 · Limited coverage
Verified filings recorded. Existing baseline history earns no points.SEC source checked:
New VC +3 · Awaiting data
No verified dated source evidence recorded.
Completed exit +10 · Awaiting data
Exit news coverage has not started.

Coverage describes public evidence. Points require a qualifying milestone after your pick.

What it does

On its website, the company describes its work as “Founded by a group of Carnegie Mellon alumni including a pediatric surgeon, PECA Labs is revolutionizing cardiovascular implantable devices with a polymer platform and a…”.

Visit pecalabs.com ↗Product description source ↗

Tracked VC backing

No tracked VC backing recorded.

A portfolio listing documents backing; its observation date is not an investment date.

Dated public activity

  • · Form D filing · Baseline

    Reported sold as filed: $12,789,342 · Offering amount as filed: $21,493,540

    SEC source checked 29 Oct 2026. Historical filing, not a current valuation.

    View original evidence ↗

History is research context. Only qualifying milestones after your pick earn points.

Company and sources ↗

QuantumScape

Tracking

Company website description

QuantumScape is on a mission to transform energy storage with revolutionary solid state battery technology that will charge faster, go farther and last longer.

Khosla Ventures
quantumscape.com ↗
Research QuantumScape

Tracking coverage

Some public sources are being tracked. Coverage varies by milestone.

Momentum +1 · Tracking
Comparable public measurements available. Points depend on your pick date.Last comparable reading:
Fundraising +2 · Awaiting data
No verified dated source evidence recorded.
New VC +3 · Awaiting data
No verified dated source evidence recorded.
Completed exit +10 · Awaiting data
Exit news coverage has not started.

Coverage describes public evidence. Points require a qualifying milestone after your pick.

Company website description

QuantumScape is on a mission to transform energy storage with revolutionary solid state battery technology that will charge faster, go farther and last longer.

Visit quantumscape.com ↗Product description source ↗

Product source checked 31 Oct 2026

Tracked VC backing

A portfolio listing documents backing; its observation date is not an investment date.

Dated public activity

No dated funding or investment events recorded yet.

History is research context. Only qualifying milestones after your pick earn points.

Company and sources ↗

Solaris Endovascular Inc.

Limited coverage

Biotechnology

On its website, the company describes its work as “With a proven stent platform and innovative drug-eluting technology, we are revolutionizing endovascular solutions for dialysis access and peripheral artery disease (PAD). Get in touch…”.

No tracked VC backing recorded
solarisendovascular.com ↗
Research Solaris Endovascular Inc.

Tracking coverage

Some source history is available; coverage remains limited.

Momentum +1 · Limited coverage
The latest public index does not report a rank for this company.Index checked:
Fundraising +2 · Limited coverage
Verified filings recorded. Existing baseline history earns no points.SEC source checked:
New VC +3 · Awaiting data
No verified dated source evidence recorded.
Completed exit +10 · Awaiting data
Exit news coverage has not started.

Coverage describes public evidence. Points require a qualifying milestone after your pick.

What it does

On its website, the company describes its work as “With a proven stent platform and innovative drug-eluting technology, we are revolutionizing endovascular solutions for dialysis access and peripheral artery disease (PAD). Get in touch…”.

Visit solarisendovascular.com ↗Product description source ↗

Tracked VC backing

No tracked VC backing recorded.

A portfolio listing documents backing; its observation date is not an investment date.

Dated public activity

  • · Form D filing · Baseline

    Reported sold as filed: $4,972,500 · Offering amount as filed: $10,000,000

    SEC source checked 29 Oct 2026. Historical filing, not a current valuation.

    View original evidence ↗

History is research context. Only qualifying milestones after your pick earn points.

Company and sources ↗

SpaceX

Tracking

Company website description

SpaceX designs, manufactures and launches advanced rockets and spacecraft. The company was founded in 2002 to revolutionize space technology, with the ultimate goal of enabling…

Sequoia Capital
spacex.com ↗
Research SpaceX

Tracking coverage

Some public sources are being tracked. Coverage varies by milestone.

Momentum +1 · Tracking
Comparable public measurements available. Points depend on your pick date.Last comparable reading:
Fundraising +2 · Awaiting data
No verified dated source evidence recorded.
New VC +3 · Awaiting data
No verified dated source evidence recorded.
Completed exit +10 · Awaiting data
Exit news coverage has not started.

Coverage describes public evidence. Points require a qualifying milestone after your pick.

Company website description

SpaceX designs, manufactures and launches advanced rockets and spacecraft. The company was founded in 2002 to revolutionize space technology, with the ultimate goal of enabling…

Visit spacex.com ↗Product description source ↗

Product source checked 31 Oct 2026

Tracked VC backing

A portfolio listing documents backing; its observation date is not an investment date.

Dated public activity

No dated funding or investment events recorded yet.

History is research context. Only qualifying milestones after your pick earn points.

Company and sources ↗

Steno

Tracking

Enterprise

Company website description

Built by tech and legal experts, Steno provides a revolutionary approach to court reporting and litigation services.

First Round Capital
steno.com ↗
Research Steno

Tracking coverage

Some public sources are being tracked. Coverage varies by milestone.

Momentum +1 · Tracking
Comparable public measurements available. Points depend on your pick date.Last comparable reading:
Fundraising +2 · Awaiting data
No verified dated source evidence recorded.
New VC +3 · Awaiting data
No verified dated source evidence recorded.
Completed exit +10 · Awaiting data
Exit news coverage has not started.

Coverage describes public evidence. Points require a qualifying milestone after your pick.

Company website description

Built by tech and legal experts, Steno provides a revolutionary approach to court reporting and litigation services.

Visit steno.com ↗Product description source ↗

Product source checked 31 Oct 2026

Source category

Enterprise

Category source ↗

Checked

Published location

Los Angeles

Location source ↗

Checked

Tracked VC backing

A portfolio listing documents backing; its observation date is not an investment date.

Dated public activity

No dated funding or investment events recorded yet.

History is research context. Only qualifying milestones after your pick earn points.

Company and sources ↗

Switch Therapeutics

Limited coverage

Company website description

Switch Therapeutics is a biotech company dedicated to revolutionizing RNA interference (RNAi) therapies with conditionally activated siRNAs (CASi).

CRV
switchthera.com ↗
Research Switch Therapeutics

Tracking coverage

Some source history is available; coverage remains limited.

Momentum +1 · Limited coverage
The latest public index does not report a rank for this company.Index checked:
Fundraising +2 · Awaiting data
No verified dated source evidence recorded.
New VC +3 · Awaiting data
No verified dated source evidence recorded.
Completed exit +10 · Awaiting data
Exit news coverage has not started.

Coverage describes public evidence. Points require a qualifying milestone after your pick.

Company website description

Switch Therapeutics is a biotech company dedicated to revolutionizing RNA interference (RNAi) therapies with conditionally activated siRNAs (CASi).

Visit switchthera.com ↗Product description source ↗

Product source checked 31 Oct 2026

Tracked VC backing

A portfolio listing documents backing; its observation date is not an investment date.

Dated public activity

No dated funding or investment events recorded yet.

History is research context. Only qualifying milestones after your pick earn points.

Company and sources ↗
How it works

Pick up to 50 companies. Your picks are private to your account.

A new US fundraising disclosure (Form D) earns 2 points. A first investment announced by a tracked VC earns 3. Milestones must occur and be observed after your pick.

Measured growth earns 1 point once: the same RiseFinder composite score rises between dated observations after your pick, using one formula version. Where available, a supported public source metric can also qualify. Lower ranks are better; rising counts are better. A completed, dated IPO or acquisition earns 10 points once.

The composite score measures relative public signals on a 0–100 scale. It is not a company valuation. Coverage varies; companies without qualifying history wait for evidence.

Initial imports, old discoveries, follow-ons from existing backers, amendments, undated events and same-day events earn no points.

Points track verified milestones after your pick. They do not represent investment returns.